These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 37985038)
1. The single-cell modification strategies for probiotics delivery in inflammatory bowel disease: A review. Han M; Lei W; Liang J; Li H; Hou M; Gao Z Carbohydr Polym; 2024 Jan; 324():121472. PubMed ID: 37985038 [TBL] [Abstract][Full Text] [Related]
2. Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives. Roy S; Dhaneshwar S World J Gastroenterol; 2023 Apr; 29(14):2078-2100. PubMed ID: 37122604 [TBL] [Abstract][Full Text] [Related]
3. Microfluidics-Derived Microparticles with Prebiotics and Probiotics for Enhanced In Situ Colonization and Immunoregulation of Colitis. Yin Y; Li Z; Gao H; Zhou D; Zhu Z; Tao L; Guan W; Gao Y; Song Y; Wang M Nano Lett; 2024 Jan; 24(4):1081-1089. PubMed ID: 38227962 [TBL] [Abstract][Full Text] [Related]
4. Beneficial Effects of Probiotics, Prebiotics, Synbiotics, and Psychobiotics in Inflammatory Bowel Disease. Wasilewski A; Zielińska M; Storr M; Fichna J Inflamm Bowel Dis; 2015 Jul; 21(7):1674-82. PubMed ID: 25822014 [TBL] [Abstract][Full Text] [Related]
5. Prebiotics and probiotics in irritable bowel syndrome and inflammatory bowel disease in children. Guandalini S; Cernat E; Moscoso D Benef Microbes; 2015; 6(2):209-17. PubMed ID: 25391345 [TBL] [Abstract][Full Text] [Related]
6. A probiotic complex, rosavin, zinc, and prebiotics ameliorate intestinal inflammation in an acute colitis mouse model. Park JS; Choi J; Kwon JY; Jung KA; Yang CW; Park SH; Cho ML J Transl Med; 2018 Feb; 16(1):37. PubMed ID: 29466999 [TBL] [Abstract][Full Text] [Related]
7. Probiotic Consortia and Their Metabolites Ameliorate the Symptoms of Inflammatory Bowel Diseases in a Colitis Mouse Model. Xu L; Liu B; Huang L; Li Z; Cheng Y; Tian Y; Pan G; Li H; Xu Y; Wu W; Cui Z; Xie L Microbiol Spectr; 2022 Aug; 10(4):e0065722. PubMed ID: 35730951 [TBL] [Abstract][Full Text] [Related]
8. Clinical effects and gut microbiota changes of using probiotics, prebiotics or synbiotics in inflammatory bowel disease: a systematic review and meta-analysis. Zhang XF; Guan XX; Tang YJ; Sun JF; Wang XK; Wang WD; Fan JM Eur J Nutr; 2021 Aug; 60(5):2855-2875. PubMed ID: 33555375 [TBL] [Abstract][Full Text] [Related]
9. Nutritional Support and Probiotics as a Potential Treatment of IBD. Tarasiuk A; Eibl G Curr Drug Targets; 2020; 21(14):1417-1427. PubMed ID: 32364071 [TBL] [Abstract][Full Text] [Related]
10. Gut microbiota and inflammatory bowel disease. Hammer HF Dig Dis; 2011; 29(6):550-3. PubMed ID: 22179210 [TBL] [Abstract][Full Text] [Related]
11. Reductase-Labile Peptidic Supramolecular Hydrogels Aided in Oral Delivery of Probiotics. Chen J; Zhang P; Wu C; Yao Q; Cha R; Gao Y ACS Appl Mater Interfaces; 2023 Jul; 15(26):31214-31223. PubMed ID: 37339324 [TBL] [Abstract][Full Text] [Related]
12. Microecology as a target for therapeutic intervention in inflammatory bowel disease. Guarner F IDrugs; 2003 Sep; 6(9):868-73. PubMed ID: 12964066 [TBL] [Abstract][Full Text] [Related]
13. Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility. Scaldaferri F; Gerardi V; Lopetuso LR; Del Zompo F; Mangiola F; Boškoski I; Bruno G; Petito V; Laterza L; Cammarota G; Gaetani E; Sgambato A; Gasbarrini A Biomed Res Int; 2013; 2013():435268. PubMed ID: 23991417 [TBL] [Abstract][Full Text] [Related]
14. Prebiotics, probiotics and helminths: the 'natural' solution? Guarner F Dig Dis; 2009; 27(3):412-7. PubMed ID: 19786773 [TBL] [Abstract][Full Text] [Related]
15. Nutritional protective mechanisms against gut inflammation. Viladomiu M; Hontecillas R; Yuan L; Lu P; Bassaganya-Riera J J Nutr Biochem; 2013 Jun; 24(6):929-39. PubMed ID: 23541470 [TBL] [Abstract][Full Text] [Related]
18. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. Hedin C; Whelan K; Lindsay JO Proc Nutr Soc; 2007 Aug; 66(3):307-15. PubMed ID: 17637082 [TBL] [Abstract][Full Text] [Related]
19. Delivery Strategies of Probiotics from Nano- and Microparticles: Trends in the Treatment of Inflammatory Bowel Disease-An Overview. Lopes SA; Roque-Borda CA; Duarte JL; Di Filippo LD; Borges Cardoso VM; Pavan FR; Chorilli M; Meneguin AB Pharmaceutics; 2023 Nov; 15(11):. PubMed ID: 38004578 [TBL] [Abstract][Full Text] [Related]
20. Probiotics, prebiotics and symbiotics in inflammatory bowel diseases: state-of-the-art and new insights. Sinagra E; Tomasello G; Cappello F; Leone A; Cottone M; Bellavia M; Rossi F; Facella T; Damiani P; Zeenny MN; Damiani F; Abruzzo A; Damiano G; Palumbo VD; Cocchi M; Jurjus A; Spinelli G; Lo Monte AI; Raimondo D J Biol Regul Homeost Agents; 2013; 27(4):919-33. PubMed ID: 24382173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]